Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Houttuynia Cordata Tablets
- Development stage
- Unknown
- Lead developer
- Guangdong Xinfeng Pharmaceutical Industry
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Compound Houttuynia Cordata Tablets (Fufang Yuxingcao Pian) is a traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Guangdong Xinfeng Pharmaceutical. It is an approved over-the-counter (OTC Class A) medication in China, indicated for the treatment of respiratory conditions such as acute pharyngitis and acute tonsillitis caused by external wind-heat. The formulation consists of five primary herbal ingredients: *Houttuynia cordata* (yuxingcao), *Scutellaria baicalensis* (huangqin), *Isatis root* (banlangen), *Forsythia* (lianqiao), and *Lonicera japonica* (jinyinhua). According to TCM principles, the drug functions to clear heat and detoxify, addressing symptoms like throat redness, swelling, and pain. As a complex herbal mixture, it does not have a single identified molecular target but relies on the synergistic effects of its botanical components.
- Brand names
- XinfengXianfeng
- Other names
- Fufang Yuxingcao Pian复方鱼腥草片Compound Yuxingcao PianCompound Houttuynia tablets
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL-6 (Interleukin 6)MMP1 (Matrix metalloproteinase-1)MMP3 (Matrix metalloproteinase-3)MMP9 (Matrix metalloproteinase-9)PGE2 (Prostaglandin E2)RELA (Nuclear Factor Kappa B Subunit p65)Mpro (3C-like proteinase of SARS-CoV-2)RdRp (Coronavirus RNA-dependent RNA polymerase)
Beyond the preview
Go deeper on Compound Houttuynia Cordata Tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Compound Houttuynia Cordata Tablets.